speb/financial-data huggingface dataset:
TTK.DE balance_sheet (quarterly, 2025-12-31) — Other Inventories: 1054000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Other Investments: 3914000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Other Investments: 3914000.00
TTK.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3149000.00
TTK.DE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1449000.00
TTK.DE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 109000.00
TTK.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 128002000.00
TTK.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 7102000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 9297000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 9297000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 3495000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 3495000.00
TTK.DE income_statement (annual, 2025-12-31) — Other Special Charges: -861000.00
TTK.DE income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TTK.DE income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TTK.DE balance_sheet (annual, 2025-12-31) — Payables: 74536000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Payables: 74536000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4914000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4914000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1915000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1915000.00
TTK.DE income_statement (annual, 2025-12-31) — Pretax Income: -148597000.00
TTK.DE income_statement (quarterly, 2025-12-31) — Pretax Income: -145797000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Properties: 203593000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Properties: 203593000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Raw Materials: 1994000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1994000.00
TTK.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 595589000.00
TTK.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 146389000.00
TTK.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 158739000.00
TTK.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 135839000.00
TTK.DE income_statement (annual, 2025-12-31) — Rent And Landing Fees: 1695000.00
TTK.DE income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 1695000.00
TTK.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
TTK.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
TTK.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: 301222000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 301222000.00
TTK.DE cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
TTK.DE cash_flow (annual, 2025-12-31) — Sale Of PPE: 2058000.00
TTK.DE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 158000.00
TTK.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 32069000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Share Issued: 65610331.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 65610331.00
TTK.DE income_statement (annual, 2025-12-31) — Special Income Charges: -125141000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 362271000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 362271000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: -29184000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -29184000.00
TTK.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -23955220.00
TTK.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TTK.DE income_statement (annual, 2025-12-31) — Tax Provision: -28357000.00
TTK.DE income_statement (quarterly, 2025-12-31) — Tax Provision: -25757000.00
TTK.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
TTK.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
TTK.DE balance_sheet (annual, 2025-12-31) — Taxes Receivable: 4761000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 4761000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Assets: 716374000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 716374000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 422698000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 422698000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Debt: 148496000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 148496000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 362271000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 362271000.00
TTK.DE income_statement (annual, 2025-12-31) — Total Expenses: 976999000.00
TTK.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 245099000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 354103000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 354103000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 500076000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 500076000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 170691000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 170691000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 14375000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 14375000.00
TTK.DE income_statement (annual, 2025-12-31) — Total Unusual Items: 95000.00
TTK.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -125420000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 1573006.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1573006.00
TTK.DE balance_sheet (annual, 2025-12-31) — Treasury Stock: 19093000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 19093000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Work In Process: 1365000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Work In Process: 1365000.00
TTK.DE balance_sheet (annual, 2025-12-31) — Working Capital: 32886000.00
TTK.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 32886000.00
TTK.DE income_statement (annual, 2025-12-31) — Write Off: 487000.00
TTK.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 91800000.00
TTK.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 225700000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 88600000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 95000000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 4300000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 64000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Basic EPS: -0.08
TTK.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 14500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1300000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -1300000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 65600000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 11500000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 22900000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Change In Inventory: -100000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -3300000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Change In Payable: 600000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -8000000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -8600000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3000000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 65600000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 360500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
TTK.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 136600000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 224300000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 177400000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 14800000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 7100000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7100000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 7100000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 7100000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 64000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.08
TTK.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — EBIT: -2600000.00
TTK.DE income_statement (quarterly, 2026-03-31) — EBITDA: 4500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 11500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2700000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -7500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -700000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 366600000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 391500000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 89100000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 2200000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2200000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Interest Income: 100000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 100000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 93100000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 360500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 500000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 4300000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 3600000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Income: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -5000000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -5000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -2100000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2100000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 6900000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 92500000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 1800000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -31000000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 7400000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 21200000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 47800000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4500000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Normalized Income: -5000000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -6200000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Operating Income: -2700000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 225700000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 65600000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 20300000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 17800000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 24900000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 500000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 39100000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 9300000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 11400000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Payables: 90400000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Pretax Income: -4800000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 136600000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7100000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 296200000.00
TTK.DE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 1800000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 65600000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 360500000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -31000000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TTK.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 200000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
TTK.DE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 4000000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 720000000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 360500000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 360500000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 228400000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 359500000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 495700000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 182100000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1800000.00
TTK.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
TTK.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 19100000.00
TTK.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 46900000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -839388000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 103306000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -16176000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Amortization: 672000.00
TTKHLTCARE.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 672000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 242866000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 14130000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Basic EPS: 29.43
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 325000000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 148642000.00
TTKHLTCARE.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 807000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 14130000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Diluted EPS: 29.43
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 4944000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 533624000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Fixed Assets Revaluation Reserve: 44143000.00
TTKHLTCARE.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: 0.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 101105000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 551978000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Interest Income: 146607000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 146607000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 178346000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 51565000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1137904000.00
TTKHLTCARE.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
TTKHLTCARE.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 27862000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 18878000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 26404000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 3155010000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 863000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Other Payable: 151848000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 51558000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Other Special Charges: -24749000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 334686000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 118600000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 175694000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 30471000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 30471000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Research And Development: 29340000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 17134000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 2009441000.00
TTKHLTCARE.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1150257000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1251362000.00
TTKHLTCARE.NS balance_sheet (annual, 2022-03-31) — Work In Process: 79926000.00
TTKHLTCARE.NS income_statement (annual, 2022-03-31) — Write Off: 1967000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — +Operating Expense: 3507736000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — +Total Revenue: 7201875000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1108679000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 920991000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -922283000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 103306000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -8531000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Amortization: 497000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 141130000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 14130000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Basic EPS: 452.72
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 148642000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 325768000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -116991000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 18004000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 141303000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 93203000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 8466687000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -141303000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 93203000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 19100000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -1842000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -71610000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Change In Payable: -104050000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -280557000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -438959000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -55439000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Common Stock: 141303000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 9533841000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 86159000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3503229000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Current Assets: 10660749000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 5855000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Current Debt: 255283000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 261138000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2107799000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 233606000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Depreciation: 129179000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 129179000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 128064000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 127567000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 14130000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Diluted EPS: 452.72
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 6397129000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 4913000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 639000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — EBIT: 668745000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — EBITDA: 797924000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — End Cash Position: 93203000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -124263000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 502500000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Fixed Assets Revaluation Reserve: 44143000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -365103000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -301000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: -7642945000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 104604000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 366000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 929522000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 1719975000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Gross Profit: 3698646000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Interest Expense: 52389000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 52389000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Interest Income: 463056000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 463056000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -28922000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 259091000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Inventory: 845146000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 9789124000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 316936000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 141130000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 51439000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 178346000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 12149000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 12149000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 30283000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1129702000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 7753133000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Net Debt: 162080000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 17000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income: 6397129000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 6397129000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 446679000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 5950450000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 6397129000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 446679000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 8380748000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 6397129000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Interest Income: 410667000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -5804613000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 51439000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 51439000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 410667000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1776926000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Net PPE: 797692000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -114388000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 51439000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 9533475000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 17036000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 43597000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30283000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 29374000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 803406000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Normalized Income: 450651857.05
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -248112000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Operating Income: 190910000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Operating Revenue: 7201875000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 14130333.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 31457000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 36411000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 366000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -410860000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 61539000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 13998000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 746893000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Payable: 160614000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Properties: 711533000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 222993000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 8373484000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Other Special Charges: 1383000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Payables: 1299381000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 3305000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 304651000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 161541000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Pretax Income: 616356000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -113383000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -5804613000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -116991000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 184405000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3503229000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 129179000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 21820000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 21820000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Research And Development: 13245000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 11934000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 8267740000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 7753133000.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 2603000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1305290000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1409894000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Share Issued: 14130333.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 51439000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Special Income Charges: -5482000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 9533841000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 9533475000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -1509142.95
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Tax Provision: 169677000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.28
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
TTKHLTCARE.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -159012000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Assets: 11701108000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 9533841000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Debt: 273287000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 9533841000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Total Expenses: 7010965000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2167267000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1040359000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 59468000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 25175000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -5482000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -5482000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Work In Process: 158241000.00
TTKHLTCARE.NS balance_sheet (annual, 2023-03-31) — Working Capital: 8552950000.00
TTKHLTCARE.NS income_statement (annual, 2023-03-31) — Write Off: 4099000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — +Operating Expense: 3821093000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — +Total Revenue: 7476394000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1022620000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 864402000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1022256000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 103306000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -8466000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Amortization: 308000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 308000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 356511000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 14130000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Basic EPS: 44.47
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 93203000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 327099000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -103834000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 13376000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 141303000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 109593000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 8452113000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -141303000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 32500000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 77093000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -124752000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 0.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 7506000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Change In Payable: -85491000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 49393000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -153344000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 16390000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Common Stock: 141303000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 10009189000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 22242000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 3405411000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Current Assets: 10772989000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 5389000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Current Debt: 214730000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 220119000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2015215000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 182593000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Depreciation: 130587000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 130587000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 130587000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 130279000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 14130000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Diluted EPS: 44.47
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 628419000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 4520000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 1081000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — EBIT: 860488000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — EBITDA: 991075000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — End Cash Position: 109593000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -219112000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 556277000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 44143000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -153267000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -2018000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of Business: 0.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 0.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 131136000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 58000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 872868000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1792498000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Gross Profit: 4070983000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Interest Expense: 19285000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 19285000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Interest Income: 621090000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 621090000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -31412000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 573357000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Inventory: 969898000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 10223919000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 284935000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 356511000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 212205000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 7987000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 7987000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 30607000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1230952000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Net Debt: 105137000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -462000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income: 628419000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 628419000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 628419000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 628419000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 628419000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 841203000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 628419000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Interest Income: 593535000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -186924000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -40553000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 593535000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Net PPE: 770242000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -102579000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -40553000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 10009131000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 54435000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30607000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 28669000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 998278000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Normalized Income: 633799986.58
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -49433000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Operating Income: 249890000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Operating Revenue: 7476394000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 14130333.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 14759000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 41137000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 9867886000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 58000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -611145000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 15855000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 1335000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 824152000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Payable: 160631000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Properties: 748000000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 270725000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 8342520000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Other Special Charges: 333000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Payables: 1244822000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: -11490000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 357203000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 180232000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Pretax Income: 841203000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -65000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -186924000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -103834000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 203165000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 3405411000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 130587000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 27642000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 27642000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -40553000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Research And Development: 11299000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 12310000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 8746258000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 1255000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1415541000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1546677000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Share Issued: 14130333.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -40553000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Special Income Charges: -7203000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 10009189000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 10009131000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -1822013.42
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Tax Provision: 212784000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 8550000.00
TTKHLTCARE.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -249569000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Total Assets: 12062998000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 10009189000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Total Debt: 228106000.00
TTKHLTCARE.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 10009189000.00
TTKHLTCARE.NS income_statement (annual, 2024-03-31) — Total Expenses: 7226504000.00